Live Longer and Cardiovascular Disease-Free
Oct 17, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Alexandria Bartley, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences
How many years can the GLP-1RA semaglutide add to your life?
It is no secret that patients with diabetes have a higher chance of developing cardiovascular disease. Patients who have chronic diabetes can eventually develop impaired blood vessels; notably, blood vessels in the heart. The glucagon-like peptide-1 receptor agonist (GLP-1 RA) class has established a clear benefit for cardiovascular disease. Semaglutide can help decrease cardiovascular events in people with type 2 diabetes who also have a high cardiovascular risk. The researchers wanted to explore deeper into semaglutide and determine how many years can be added to a patient's life with this drug's addition. It is imperative to establish how many years a patient with type 2 diabetes can benefit from a drug used to prevent cardiovascular disease. Also, it is believed that even clinicians have a tough time interpreting and relating results from trials to patients. Generally, a patient wants to know how they can benefit from another drug being added to their possibly already complicated drug regimen....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.